The WACC of Anika Therapeutics Inc (ANIK) is 5.6%.
Range | Selected | |
Cost of equity | 6.30% - 8.20% | 7.25% |
Tax rate | 18.90% - 22.40% | 20.65% |
Cost of debt | 5.00% - 5.00% | 5.00% |
WACC | 5.2% - 6.0% | 5.6% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 0.53 | 0.6 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 6.30% | 8.20% |
Tax rate | 18.90% | 22.40% |
Debt/Equity ratio | 1 | 1 |
Cost of debt | 5.00% | 5.00% |
After-tax WACC | 5.2% | 6.0% |
Selected WACC | 5.6% | |